← FDA DRUG APPROVALS

FDA ANDA · ANDA078635

BISOPROLOL FUMARATE

Sponsor: UNICHEM

APPLICATION
ANDA078635
TYPE
ANDA
ORIGINAL APPROVAL
2009-08-18
LATEST ACTION
2019-08-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

BISOPROLOL FUMARATEPrescription
BISOPROLOL FUMARATE 5MG · TABLET · ORAL
BISOPROLOL FUMARATEPrescription
BISOPROLOL FUMARATE 10MG · TABLET · ORAL

Approval history

2019-08-07Labeling · Supplement 17 · standardAP
2016-08-19Manufacturing (CMC) · Supplement 8AP
2015-05-26Labeling · Supplement 1AP
2009-08-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →